Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • How big is the problem?
    • How we drive change
    • Our story
  • Featured insights
    • The latest at the Foundation
    • The latest at the Foundation
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company report cards & comparison
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • Become a catalyst
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
    • For investors
    • For companies
    • For government and policy makers
    • Events & engagements
  • Achievements so far
    • The Foundation's impact
    • The Foundation's impact
  • News
  • Our team
  • Our impact
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us
Photo of: Monica Thomas
Investor Engagement Officer

Monica Thomas

Monica is the Investor Engagement Officer for the Strategy team at the Access to Medicine Foundation. She supports the Foundation’s ongoing conversations with institutional investors about the Foundation's research. Numerous portfolio managers, healthcare analysts and ESG professionals already work with the Foundation to improve their knowledge of how pharmaceutical companies manage risks and opportunities related to access-to-medicine and antimicrobial resistance (AMR). More than 120 institutional investors have already pledged their support by signing the Access to Medicine Index Investor Statement. Together, these investors manage assets in excess of USD 21 trillion.

Monica has a background in law, having obtained a master’s degree in international Trade and Investment Law from the University of Amsterdam and an honours degree from the University of Strathclyde. Monica has published her thesis on World Trade Organisation mechanisms that could be used to increase supply of COVID-19 vaccines by generic manufacturers in LMICs, focussing on a waiver of international intellectual property rights and compulsory licensing under the TRIPS agreement. During her studies, Monica volunteered as a junior business associate for the International Citizen Service, a UK government-funded development programme. In this role she conducted a consulting role on small and micro-enterprise projects in Ghana. 

The Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Copyright 2004 - 2022 Access to Medicine Foundation - All Rights Reserved